Form 8-K - Current report:
SEC Accession No. 0001558370-20-011405
Filing Date
2020-10-07
Accepted
2020-10-07 16:15:40
Documents
15
Period of Report
2020-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20201007x8k.htm   iXBRL 8-K 46672
2 EX-1.1 glyc-20201007xex1d1.htm EX-1.1 241641
3 EX-5.1 glyc-20201007xex5d1.htm EX-5.1 12913
4 GRAPHIC glyc-20201007xex5d1001.jpg GRAPHIC 3070
  Complete submission text file 0001558370-20-011405.txt   473508

Data Files

Seq Description Document Type Size
5 EX-101.SCH glyc-20201007.xsd EX-101.SCH 3224
6 EX-101.LAB glyc-20201007_lab.xml EX-101.LAB 15499
7 EX-101.PRE glyc-20201007_pre.xml EX-101.PRE 10518
8 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20201007x8k_htm.xml XML 4664
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 201229268
SIC: 2834 Pharmaceutical Preparations